Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,0213,040 of 20,252 grants

Active RESEARCH CENTERS
CEP: Career Enhancement Program
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2023 – 2028

PROJECT SUMMARY – CAREER ENHANCEMENT PROGRAM (CEP) The mission of the Hillman Cancer Center (HCC) Ovarian Cancer (OvCa) SPORE Career Enhancement Program (CEP) is to foster the deve...

Active NON-SBIR/STTR RPGS
Znf740 in the regulation of CD8+T cell exhaustion
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

ABSTRACT: CAR-T cell therapy is an emerging option for cancer treatment, but its efficacy is limited, especially in solid tumors, because the effector CD8+T cells become dysfunctio...

$4.67M
USD
Active NON-SBIR/STTR RPGS
Enhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and Tumorigenesis
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2023 – 2028

Enhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and Tumorigenesis Summary: Our long-term goal is to determine how MYC’s RNA binding function contributes t...

$4.34M
USD
Active NON-SBIR/STTR RPGS
Development and Evaluation of Advanced Non-Contrast Perfusion MRI for Monitoring Treatment Response in Brain Metastases
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Project Abstract Brain metastases (BM) are the most commonly diagnosed type of central nervous system tumor, more frequent than primary intracranial neoplasms. Progress on various...

$6.58M
USD
Active NON-SBIR/STTR RPGS
Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck
NATIONAL CANCER INSTITUTE Arizona State University-Tempe Campus United States 2023 – 2026

Abstract Profiling antibody response to disease-associated antigens is important to cancer research. In contrast to the historical approach of testing responses to individual prote...

$3.91M
USD
Active NON-SBIR/STTR RPGS
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

Project Summary There remains a need to develop biomarker tests for personalized risk assessment of breast and ovarian cancers. Such tests would not replace screening programs but...

$6.72M
USD
Active NON-SBIR/STTR RPGS
Transcription and Replication of Oncogenic Viruses in Hypoxia
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Summary Oncogenic viruses are major contributors to approximately 20% of human cancers, with about 8 well-known viruses directly shown to be causative agents. Our program will focu...

$26.97M
USD
Active NON-SBIR/STTR RPGS
Project 1: KSHV reprograms replication and metabolic activities in hypoxia
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Project #1 Abstract KSHV-associated cancers occur in hypoxic microenvironments. The effects of hypoxia on viral and host DNA replication in the context of KSHV infection are poorly...

Active NON-SBIR/STTR RPGS
Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Summary Hypoxia is a characteristic feature of solid tumors and an adverse prognostic factor owing to its contributions to tumor progression and resistance to therapy. Kaposi'...

Active NON-SBIR/STTR RPGS
Project 3: Skin hypoxia, MCPyV infection, and MCC tumorigenesis
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Project Abstract Merkel cell carcinoma (MCC) is one of the most aggressive skin cancers. Clonal integration of Merkel cell polyomavirus (MCPyV) genome into the host DNA has been ob...

Active NON-SBIR/STTR RPGS
Project 4: Regulation of EBV Latency and Oncogenesis by Hypoxia
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Abstract: Epstein-Barr Virus (EBV) a human gammaherpesvirus that is associated with diverse lymphoid and epithelial malignancies. Like all cancers, EBV-associated cancers must comp...

Active NON-SBIR/STTR RPGS
Administrative Core
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Abstract Core A: Program Administration The mission of the Administrative core is to maintain a cohesive program through facilitating interactions between the three projects and th...

Active NON-SBIR/STTR RPGS
Virus, Vector and Cell Culture Core
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Abstract Core B: Virus Vector and Cell Culture Core The Virus Vector and Cell Culture Core (VVCCC) will be responsible for 1) recombinant virus design consultation, 2) vector and v...

Active NON-SBIR/STTR RPGS
Next Generation Sequencing Core
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

Summary Core C: Next Generation Sequencing core (NGSC) The next generation sequencing core (NGSC) will be responsible for all next generation sequencing activities by the four proj...

Completed NON-SBIR/STTR RPGS
Development of Mouse and Humanized Models to Study Sex Disparities in Tumor Progression and Treatment of NSCLC
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2025

Project Summary According to the American Cancer Society, lung cancer is the second most commonly diagnosed cancer in men and women. Outside of the sex-specific cancers, lung cance...

$2.18M
USD
Completed NON-SBIR/STTR RPGS
Anticancer Effects of a Repurposed Drug in Colon Cancer
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT About 25–30% of confirmed colon cancers (CC) without detectable local or distal invasion will eventually develop metastases, and there is currently no cure...

$3.82M
USD
Active NON-SBIR/STTR RPGS
Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment
NATIONAL CANCER INSTITUTE Kaiser Foundation Research Institute United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT More than 3.8 million women living in the United States have a history of invasive breast cancer, a majority of whom are over age 65. With 15-year survival...

$6.57M
USD
Completed NON-SBIR/STTR RPGS
Define the oncogenic role of Plk1 during hepatocellular carcinoma development using a genetically modified mouse model
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2025

Hepatocellular carcinoma (HCC) represents one of the most common malignancies in humans and the leading cause of cancer-related death worldwide, with a steadily increasing incidenc...

$1.55M
USD
Active NON-SBIR/STTR RPGS
Human mast cells as a platform for new cancer immunotherapy strategies
NATIONAL CANCER INSTITUTE Liberty University, Inc United States 2023 – 2026

ABSTRACT The role of human tissue mast cells (MC) in the pathology of many cancers is not known. Correlative studies in humans have found high MC numbers in the tumor microenvironm...

$3.73M
USD
Active OTHER RESEARCH-RELATED
Cancer Adoptive Cell Therapy (Can-ACT) Network Coordinating Center at Mayo Clinic
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT – NETWORK COORDINATING CENTER The Network Coordinating Center (NCC) will facilitate and be responsible for network-wide coordination and harmonization of s...

$4.8M
USD